Clinical trials
Phase 1 Schizophrenia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
191 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 11 |
| 2008 | 8 |
| 2009 | 14 |
| 2010 | 9 |
| 2011 | 17 |
| 2012 | 14 |
| 2013 | 16 |
| 2014 | 11 |
| 2015 | 10 |
| 2016 | 10 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 12 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 164 |
| Terminated | 13 |
| Recruiting | 7 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 24 |
| Yale University | 11 |
| Pfizer | 7 |
| Luye Pharma Group Ltd. | 6 |
| Sumitomo Pharma America, Inc. | 6 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 6 |
| Biogen | 5 |
| Merck Sharp & Dohme LLC | 5 |
| University of California, San Francisco | 5 |
| Alkermes, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 191 |
| Psychotic Disorders | 50 |
| Bipolar Disorder | 12 |
| Mental Disorders | 8 |
| Schizophrenia Spectrum and Other Psychotic Disorders | 5 |
| Major Depressive Disorder | 3 |
| Alzheimer Disease | 2 |
| Autism Spectrum Disorder | 2 |
| Cognitive Dysfunction | 2 |
| Marijuana Abuse | 2 |
Trials
Showing 1 to 25 of 191. Each trial links to its page on Pharma Observatory.
91 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.